Cargando…
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in Wuhan, China, and has subsequently spread worldwide. In the absence of any antiviral or immunomodulatory therapies, the disease is spreading at an alarming rate. A possibility of a resurgence of COVID-19...
Autores principales: | Kalita, Parismita, Padhi, Aditya K., Zhang, Kam Y.J., Tripathi, Timir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196559/ https://www.ncbi.nlm.nih.gov/pubmed/32376359 http://dx.doi.org/10.1016/j.micpath.2020.104236 |
Ejemplares similares
-
Corrigendum to “Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2” [Microbial Pathog. 145 (2020) 104236]
por: Kalita, Parismita, et al.
Publicado: (2021) -
Computational Protein Design for COVID-19 Research
and Emerging Therapeutics
por: Kalita, Parismita, et al.
Publicado: (2023) -
Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation
por: Padhi, Aditya K., et al.
Publicado: (2021) -
An efficient protocol to enhance recombinant protein expression using ethanol in Escherichia coli
por: Chhetri, Gaurav, et al.
Publicado: (2015) -
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
por: Padhi, Aditya K., et al.
Publicado: (2022)